To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here



It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

Worldwide Healthcare Trust PLC

Change Share Class?

Worldwide Healthcare Trust PLC Ord
  • This fund only has one share class
Select Performance Currency
Pound Sterling
  • What is the Fund’s objective?

    To invest in the global healthcare sector with the objective of achieving a high level of capital growth. In order to achieve its investment objective, the Company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to enhance returns and mitigate risk.

    How does FE rate this fund?

    • No FE Alpha managers
    • 4
    • Not included in the AFI

    Who manages this fund?

    Samuel D Isaly Since 01-Apr-1995

    Samuel D. Isaly has been active in international and healthcare investment throughout his career, beginning at Chase...


    Sven H Borho Since 01-Apr-1995

    Sven H. Borho, CFA, is a founding General Partner of OrbiMed. Mr. Borho is a portfolio manager for OrbiMed's public...


  • How has this fund performed?

    Cumulative Performance chart

    Cumulative Performance as at 27/04/2017
        3m 6m 1yr 3yrs 5yrs
    Worldwide Healthcare Trust PLC Ord +8.4 +11.4 +30.3 +93.0 +214.4
    Biotechnology & Healthcare +6.8 +9.2 +25.8 +81.7 +183.7
    NAV +5.1 +5.4 +22.1 +81.7 +173.4

    Discrete Performance chart

  • Forensic News Alerts

  • Ratios and Analysis

    How does this fund compare against other funds in Biotechnology & Healthcare?

    Quartile Ranking

        1y 3y
    ? Position 2 / 4 2 / 4
    ? Quartile 2 2

    Ranking is for the main unit within the sector View other funds in this sector

    Other Rating

    Morningstar Analyst

    Ratio Info

        1y 3y
    ? Volatility 17.65 19.33
    ? Alpha -1.19 2.10
    ? Beta 1.04 0.93
    ? Sharpe 1.81 0.96
    ? Info Ratio -0.04 0.09
    ? R2 0.84 0.89
    ? Quartiles:1 2 3 4

    Risk Score

    FE Risk scores allow you to see how risky a fund is in comparison with the FTSE 100.

    This fund: 159
    FTSE 100: 100
    Cash: 0

    Investment Details

    Initial 0.00%
    Annual 0.65%
    ? OCF 1.00%
    Minimum Investment?
    Initial n/a
    Additional n/a
  • Prices and Codes


                Diluted NAV   Div yield
      Currency Bid Offer Date Prem/Disc Estimated Last Published Gearing Net Gross
    Worldwide Healthcare Trust PLC Ord GBX 2309.00 27 Apr 2017 -0.84 2328.65 2328.65 100 0.71 0.71


      Unit type Exchange TIDM Citicode SEDOL ISIN
    Worldwide Healthcare Trust PLC Ord ACC WWH FD95 0338530 GB0003385308
  • What does this fund invest in?

    Asset Class Breakdown (28 Feb 2017)

    Rank Asset %    
    1 North American Equities 64.40
    2 European Equities 15.30
    3 Global Emerging Market Equities 13.40
    4 Asia Pacific Equities 6.90

    Top Holdings (28 Feb 2017)

    Rank Largest Holdings %  
    2 MERCK & CO INC(NEW) 4.50
    3 Boston Scientific Corp ORD 4.20
    5 Ely Lilly & Co 3.60
    6 INCYTE CORP 3.50
    7 BIOGEN INC 3.40
    8 HCA 3.10
    9 Roche 3.00
    10 Nippon Shinyaku 2.60
  • Additional Information

    Additional Information

    Legal Structure: INVT
    Nominal value: 2500
    Fund Launch: 01-Apr-1995
    Unit Launch: 01-Apr-1995
    Savings plan: Minimum: £ 100.0 Monthly
    Last AGM: 21-Sep-2016
    Stockbroker(s): Winterflood Investment Trusts
    Wind-up date: N/A
    Dividend policy: N/A
    Settlement Details: N/A
    Issued: N/A
    Asset Class: Equity
    Annual accounts: N/A
    Next AGM: September 2017
    Management Contract: Frostrow Capital LLP receives a periodic fee equal to 0... More
    Continuation/Wind-up provision: Continuation vote passed at the AGM in 2009 and will be... More
    Investment Restrictions: N/A
    Tax Policy: N/A
    Fund Size: £1,073.8m / $1,385.3m (27-Apr-17)
    Market Value: £ 1073.83m
    Own ISA wrapper: YES help with ISA
    Last report / accounts: 25-Nov-2016
    EGM: 09-Apr-2015
    Borrowing limits: N/A
    Splits: N/A
    Reconstruction proposal: N/A
    News: company announcements
  • News and Research about this fund

    Relevant articles

    Relevant Guides

  • Contact Details

    Frostrow Capital LLP, 25 Southampton Buildings, London, WC2A 1AL

    0203 043 8889 (Fax Number)
    0203 008 4910 (Main Number)

Annual Management Charges: 0.65% of net assets plus 0.30% of market cap. up to £150m and 0.20% > £150m and 0.125% > £500m plus £57,500;

All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated using closing mid prices and with net income (dividends) reinvested. fair value cum income NAV figures (in accordance with AIC guidelines) and with net income (dividends) reinvested. Performance figures are shown in Pound Sterling (GBP). You can switch the fund’s native currency using the currency selector towards the top of this page.

Your custom layout changed and saved automatically
Drag and drop the icon to customise your factsheet layout
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close